The process of vetting experimental drugs is designed, with safety in mind, to be cautiously meticulous.
Still, things sometimes go wrong, as in France where the authorities announced Friday that tests with a candidate painkiller left one person brain-dead and five in hospital.
How drug trials work:
After preliminary tests on animals and human cells in petri dishes, a laboratory must obtain permission from health authorities for clinical trials on humans to assess a drug's safety and effectiveness.
This testing usually consists of three phases:
-- Phase I is generally carried out with a sample of fewer than 100 healthy volunteers to assess drug tolerance and check for side-effects. The French trial was in this phase.
Normally, Phase I involves young adults who have passed a medical examination to declare them in tip-top shape.
-- After safety has been established, Phase II evaluates the effectiveness of the drug and the optimal dosage, usually on a sample of several hundred people.
-- Phase III compares the treatment to a dummy drug (placebo) or a medicine already in use -- usually testing it on several thousand people. The aim is to confirm the drug's effectiveness.
Some trials take place in hospitals, others at licensed private institutions.
After clinical trials, which can last between five and 10 years, the laboratory applies to a medicines watchdog to bring the drug to market.
In Europe, this is the European Medicines Agency (EMA), and in the United States it is the Food and Drug Administration (FDA).
For approval, a new treatment must demonstrate a benefit/risk ratio that is equivalent to, or better than, any existing drug.
According to the French National Agency for Medicines and Health Products Safety (ANSM), it can take 10 to 15 years from when a drug is first tested in a laboratory to it reaching the market.
Once it becomes commercially available, any new drug remains under surveillance and ongoing assessment of any side effects.
If there are any health risks, it can be taken off the shelves at any time.
GMT 08:29 2018 Sunday ,21 January
Hot air? Study finds bikram no healthier than other yogaGMT 05:12 2018 Saturday ,13 January
'How much do you earn?' Germany takes on gender pay gapGMT 02:56 2017 Friday ,15 December
Will Trump send Americans to the Moon? Money talksGMT 04:01 2017 Saturday ,18 November
What is the Paris Agreement?GMT 07:05 2017 Thursday ,09 November
Could the peatlands of Congo be a carbon bomb?GMT 04:49 2017 Wednesday ,13 September
So how do mega-storms get named, anyhow?GMT 16:43 2017 Wednesday ,09 August
Want to learn something? Sleep on it, but not too deeplyGMT 21:25 2017 Monday ,31 July
Is 'diesel summit' the last chance for Germany's favourite engine?Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor